Ohr Pharmaceutical (OHRP) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts OHRP Hot Sheet
Join SI Premium – FREE
Ohr Pharmaceutical (NASDAQ: OHRP) reported Q4 EPS of ($0.20), in-line with the analyst estimate of ($0.20).
For earnings history and earnings-related data on Ohr Pharmaceutical (OHRP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Edwards Lifesciences (EW) Tops Q1 EPS by 2c; offers guidance
- Seacoast Banking Corporation of Florida (SBCF) Tops Q1 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
